Search

Your search keyword '"Kontoyiannis, Dimitrios P."' showing total 2,435 results
Start Over Author "Kontoyiannis, Dimitrios P."
2,435 results on '"Kontoyiannis, Dimitrios P."'

51. Panel stacking is a threat to consensus statement validity

Author

Kepp, Kasper P., Aavitsland, Preben, Ballin, Marcel, Balloux, Francois, Baral, Stefan, Bardosh, Kevin, Bauchner, Howard, Bendavid, Eran, Bhopal, Raj, Blumstein, Daniel T., Boffetta, Paolo, Bourgeois, Florence, Brufsky, Adam, Collignon, Peter J., Cripps, Sally, Cristea, Ioana A., Curtis, Nigel, Djulbegovic, Benjamin, Faude, Oliver, Flacco, Maria Elena, Guyatt, Gordon H., Hajishengallis, George, Hemkens, Lars G., Hoffmann, Tammy, Joffe, Ari R., Klassen, Terry P., Koletsi, Despina, Kontoyiannis, Dimitrios P., Kuhl, Ellen, La Vecchia, Carlo, Lallukka, Tea, Lambris, John, Levitt, Michael, Makridakis, Spyros, Maltezou, Helena C., Manzoli, Lamberto, Marusic, Ana, Mavragani, Clio, Moher, David, Mol, Ben W., Muka, Taulant, Naudet, Florian, Noble, Paul W., Nordström, Anna, Nordström, Peter, Pandis, Nikolaos, Papatheodorou, Stefania, Patel, Chirag J., Petersen, Irene, Pilz, Stefan, Plesnila, Nikolaus, Ponsonby, Anne-Louise, Rivas, Manuel A., Saltelli, Andrea, Schabus, Manuel, Schippers, Michaéla C., Schünemann, Holger, Solmi, Marco, Stang, Andreas, Streeck, Hendrik, Sturmberg, Joachim P., Thabane, Lehana, Thombs, Brett D., Tsakris, Athanasios, Wood, Simon N., and Ioannidis, John P.A.

Published
2024
Full Text
View/download PDF

55. Phenotypic Differences of Cryptococcus Molecular Types and Their Implications for Virulence in a Drosophila Model of Infection

Author

Thompson, George R, Albert, Nathaniel, Hodge, Greg, Wilson, Machelle D, Sykes, Jane E, Bays, Derek J, Firacative, Carolina, Meyer, Wieland, and Kontoyiannis, Dimitrios P

Subjects
Microbiology, Biological Sciences, Biomedical and Clinical Sciences, Infectious Diseases, Emerging Infectious Diseases, 2.2 Factors relating to the physical environment, Aetiology, Infection, Animals, Antifungal Agents, Cryptococcus gattii, Drosophila melanogaster, Drug Resistance, Fungal, Gene Expression Regulation, Bacterial, Melanins, Virulence, Agricultural and Veterinary Sciences, Medical and Health Sciences, Immunology, Medical microbiology
Abstract

Compared to Cryptococcus neoformans, little is known about the virulence of the molecular types in Cryptococcus gattii. We compared in vitro virulence factor production and survival data using a Drosophila model of infection to further characterize the phenotypic features of different cryptococcal molecular types. Forty-nine different isolates were inoculated into wild-type flies and followed for survival. In vitro, isolates were assessed for growth at 30 and 37°C, melanin production, capsule size, resistance to H(2)O(2), and antifungal susceptibility. A mediator model was used to assess molecular type and virulence characteristics as predictors of survival in the fly model. VGIII was the most virulent molecular type in flies (P < 0.001). At 30°C, VGIII isolates grew most rapidly; at 37°C, VNI isolates grew best. C. gattii capsules were larger than those of C. neoformans (P < 0.001). Mediator model analysis found a strong correlation of Drosophila survival with molecular type and with growth at 30°C. We found molecular-type-specific differences in C. gattii in growth at different temperatures, melanin production, capsule size, ability to resist hydrogen peroxide, and antifungal susceptibility, while growth at 30°C and the VGIII molecular type were strongly associated with virulence in a Drosophila model of infection.

Published
2014

56. Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib: A Case Report and Review of the Literature on Ruxolitinib-Associated Invasive Fungal Infections.

Author

Chiu, Chia-Yu, John, Teny M., Matsuo, Takahiro, Wurster, Sebastian, Hicklen, Rachel S., Khattak, Raihaan Riaz, Ariza-Heredia, Ella J., Bose, Prithviraj, and Kontoyiannis, Dimitrios P.

Subjects
HISTOPLASMOSIS, LITERATURE reviews, MYCOSES, RUXOLITINIB, JANUS kinases, MYELOFIBROSIS
Abstract

Ruxolitinib, a selective inhibitor of Janus kinases, is a standard treatment for intermediate/high-risk myelofibrosis (MF) but is associated with a predisposition to opportunistic infections, especially herpes zoster. However, the incidence and characteristics of invasive fungal infections (IFIs) in these patients remain uncertain. In this report, we present the case of a 59-year-old woman with MF who developed disseminated histoplasmosis after seven months of ruxolitinib use. The patient clinically improved after ten weeks of combined amphotericin B and azole therapy, and ruxolitinib was discontinued. Later, the patient received fedratinib, a relatively JAK2-selective inhibitor, without relapse of histoplasmosis. We also reviewed the literature on published cases of proven IFIs in patients with MF who received ruxolitinib. Including ours, we identified 28 such cases, most commonly due to Cryptococcus species (46%). IFIs were most commonly disseminated (39%), followed by localized lung (21%) infections. Although uncommon, a high index of suspicion for opportunistic IFIs is needed in patients receiving JAK inhibitors. Furthermore, the paucity of data regarding the optimal management of IFIs in patients treated with JAK inhibitors underscore the need for well-designed studies to evaluate the epidemiology, pathobiology, early diagnosis, and multimodal therapy of IFIs in patients with hematological malignancies receiving targeted therapies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

57. Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes.

Author

Matsuo, Takahiro, Wurster, Sebastian, Jiang, Ying, Sasaki, Koji, Tarrand, Jeffrey, Lewis, Russell E, and Kontoyiannis, Dimitrios P

Subjects
BREAKTHROUGH infections, FUSARIOSIS, LEUKEMIA, AZOLES, POISSON regression, ANTIFUNGAL agents
Abstract

Objectives Historically, patients with leukaemia and invasive fusariosis (IF) have experienced poor outcomes in the setting of persistent immunosuppression. Herein, we retrospectively reviewed the incidence, presentation and outcomes of IF that are scarcely studied in contemporary cohorts of leukaemia patients. Methods We identified adult leukaemia patients with proven or probable IF at MD Anderson Cancer Center during 2009–21. Independent risk factors for 42 day mortality after IF diagnosis were determined using a multivariable logistic regression model. Combined with historical data, the annual IF incidence density over the past 23 years was estimated using Poisson regression analysis. Results Among 140 leukaemia patients with IF (114 proven), 118 patients (84%) had relapsed/refractory leukaemia and 124 (89%) had neutropenia at IF diagnosis. One hundred patients (71%) had pulmonary IF, 88 (63%) had disseminated IF and 48 (34%) had fungaemia. Coinfections were common (55%). Eighty-nine patients (64%) had breakthrough IF to mould-active triazoles. Most patients (84%) received combination antifungal therapy. Neutrophil recovery [adjusted OR (aOR), 0.04; 95% CI, 0.01–0.14; P  < 0.0001], pulmonary IF (aOR, 3.28; 95% CI, 1.11–9.70; P  = 0.032) and high SOFA score (aOR, 1.91 per 1-point increase; 95% CI, 1.47–2.50; P  < 0.0001) were independent predictors of 42 day mortality outcomes. From 1998 to 2021, IF incidence density increased significantly at an annual ratio of 1.03 (95% CI, 1.01–1.06; P  = 0.04). Conclusions IF is predominantly seen in patients with relapsed/refractory leukaemia and increasingly seen as a breakthrough infection to mould-active triazoles. Despite frequent combination antifungal therapy, high mortality rates have persisted in patients with lasting neutropenia. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

58. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept

Author

Aminu, Muhammad, primary, Daver, Naval, additional, Godoy, Myrna C. B., additional, Shroff, Girish, additional, Wu, Carol, additional, Torre-Sada, Luis F., additional, Goizueta, Alberto, additional, Shannon, Vickie R., additional, Faiz, Saadia A., additional, Altan, Mehmet, additional, Garcia-Manero, Guillermo, additional, Kantarjian, Hagop, additional, Ravandi-Kashani, Farhad, additional, Kadia, Tapan, additional, Konopleva, Marina, additional, DiNardo, Courtney, additional, Pierce, Sherry, additional, Naing, Aung, additional, Kim, Sang T., additional, Kontoyiannis, Dimitrios P., additional, Khawaja, Fareed, additional, Chung, Caroline, additional, Wu, Jia, additional, and Sheshadri, Ajay, additional

Published
2023
Full Text
View/download PDF

64. Update on mucormycosis pathogenesis

Author

Ibrahim, Ashraf S and Kontoyiannis, Dimitrios P

Subjects
Emerging Infectious Diseases, Infectious Diseases, Aetiology, 2.1 Biological and endogenous factors, Infection, Good Health and Well Being, Antifungal Agents, Azoles, Host-Pathogen Interactions, Humans, Immunocompromised Host, Iron, Mucorales, Mucormycosis, Risk Factors, innate, adaptive immunity, invasion, iron uptake, mucormycosis, Microbiology, Clinical Sciences, Medical Microbiology
Abstract

Purpose of reviewMucormycosis is an increasingly common fungal infection with unacceptably high mortality. The recent sequencing genome projects of Mucorales and the development of gene manipulation have enabled significant advances in understanding the pathogenesis of mucormycosis. Therefore, we review the pathogenesis of mucormycosis and highlight potential development of novel diagnostic and therapeutic modalities against this lethal disease.Recent findingsMuch of the work has been focused on the role of iron uptake in the virulence of Mucorales. Additionally, host receptors and fungal ligands involved in the process of tissue invasion as well as sporangiospore size and sex loci and their contribution to virulence of Mucorales are discussed. Finally, the role of innate and adaptive immunity in protection against Mucorales and new evidence about drug-induced apoptosis in these fungi are discussed.SummaryRecent discoveries introduce several potentially novel diagnostic and therapeutic modalities, which are likely to improve management and outcome for mucormycosis. Future preclinical and clinical research is warranted to develop these diagnostic and therapeutic strategies.

Published
2013

67. Fungal Infections in Immunocompromised Hosts

Author

Kontoyiannis, Dimitrios P. and Slavin, Monica

Abstract

In this unique supplement, we have compiled several state-of-the-art topics that are based on lectures delivered by eminent mycology experts during the 37th ICHS meeting. We hope that the esteemed audience of the Journal of Fungi will enjoy and appreciate the ever-evolving and complex field of fungal infections in vulnerable hosts.

Published
2019

77. Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.

Author

Chiu, Chia‐Yu, Matsuo, Takahiro, Wurster, Sebastian, Gerstein, Yoheved, Hammond, Danielle E., Chien, Kelly S., DiNardo, Courtney, and Kontoyiannis, Dimitrios P.

Subjects
MYCOSES, LITERATURE reviews, KILLER cells, ACUTE myeloid leukemia, HUMAN papillomavirus
Abstract

Germline pathogenic variants (PVs) in the gene encoding the GATA2 transcription factor can result in profound reductions of monocytes, dendritic cells, natural killer cells and B cells. GATA2 PVs are associated with an increased risk of myeloid malignancies and a predisposition to nontuberculous mycobacterial and human papillomavirus infections. Additionally, invasive fungal infections (IFIs) have been reported in individuals with GATA2 PVs, even in the absence of myeloid malignancies. In this report, we present the case of a 40‐year‐old man with Emberger syndrome (GATA2 mutation, recently diagnosed acute myeloid leukaemia [AML] and history of lymphedema with hearing loss) who developed Mucorales sinusitis while receiving his first course of remission induction chemotherapy. Additionally, we review the literature on all published cases of proven IFIs in patients with GATA2 PVs. Clinicians should be aware that patients with GATA2 PVs could be vulnerable to opportunistic IFIs, even in the absence of AML and antineoplastic therapy. Furthermore, the distinctly unusual occurrence of mucormycosis during the first course of induction chemotherapy for AML in our patient indicates that patients with germline GATA2 PVs receiving induction chemotherapy for AML might be at high risk for early onset of IFIs due to aggressive, opportunistic moulds. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

80. Calcium sequestration by fungal melanin inhibits calcium–calmodulin signalling to prevent LC3-associated phagocytosis

Author

Kyrmizi, Irene, Ferreira, Helena, Carvalho, Agostinho, Figueroa, Julio Alberto Landero, Zarmpas, Pavlos, Cunha, Cristina, Akoumianaki, Tonia, Stylianou, Kostas, Deepe, Jr, George S., Samonis, George, Lacerda, João F., Campos, Jr, António, Kontoyiannis, Dimitrios P., Mihalopoulos, Nikolaos, Kwon-Chung, Kyung J., El-Benna, Jamel, Valsecchi, Isabel, Beauvais, Anne, Brakhage, Axel A., Neves, Nuno M., Latge, Jean-Paul, and Chamilos, Georgios

Published
2018
Full Text
View/download PDF

83. Invasive Mold Infections Following Hurricane Harvey—Houston, Texas

Author

Toda, Mitsuru, primary, Williams, Samantha, additional, Jackson, Brendan R, additional, Wurster, Sebastian, additional, Serpa, Jose A, additional, Nigo, Masayuki, additional, Grimes, Carolyn Z, additional, Atmar, Robert L, additional, Chiller, Tom M, additional, Ostrosky-Zeichner, Luis, additional, and Kontoyiannis, Dimitrios P, additional

Published
2023
Full Text
View/download PDF

84. Multimodal analysis of the COVID ‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors

Author

Chowdhary, Anuradha, primary, Gupta, Nitesh, additional, Wurster, Sebastian, additional, Kumar, Raj, additional, Mohabir, Jason T., additional, Tatavarthy, Shashidhar, additional, Mittal, Vikas, additional, Rani, Preeti, additional, Barman, Purabi, additional, Sachdeva, Neelam, additional, Singh, Ashutosh, additional, Sharma, Brijesh, additional, Jiang, Ying, additional, Cuomo, Christina A., additional, and Kontoyiannis, Dimitrios P., additional

Published
2023
Full Text
View/download PDF

87. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Author

Maertens, Johan A, Raad, Issam I, Marr, Kieren A, Patterson, Thomas F, Kontoyiannis, Dimitrios P, Cornely, Oliver A, Bow, Eric J, Rahav, Galia, Neofytos, Dionysios, Aoun, Mickael, Baddley, John W, Giladi, Michael, Heinz, Werner J, Herbrecht, Raoul, Hope, William, Karthaus, Meinolf, Lee, Dong-Gun, Lortholary, Olivier, Morrison, Vicki A, Oren, Ilana, Selleslag, Dominik, Shoham, Shmuel, Thompson, George R, III, Lee, Misun, Maher, Rochelle M, Schmitt-Hoffmann, Anne-Hortense, Zeiher, Bernhardt, and Ullmann, Andrew J

Published
2016
Full Text
View/download PDF

90. Contributors

Author

Abdel-Wahab, Omar, primary, Abrahm, Janet L., additional, Adams, Sharon, additional, Adewoye, Adeboye H., additional, Allen, Carl, additional, Ambinder, Richard F., additional, Anasetti, Claudio, additional, Anastasi, John, additional, Anderson, Julia A., additional, Antin, Joseph H., additional, Antony, Aśok C., additional, Araten, David J., additional, Armand, Philippe, additional, Armstrong, Gillian, additional, Armstrong, Scott A., additional, Arnold, Donald M., additional, Artz, Andrew S., additional, Awan, Farrukh T., additional, Baglin, Trevor P., additional, Benson, Don M., additional, Benz, Edward J., additional, Berliner, Nancy, additional, Bhagat, Govind, additional, Bhardwaj, Nina, additional, Bhatia, Ravi, additional, Bhatia, Smita, additional, Bhatt, Mihir D., additional, Bhatt, Vijaya Raj, additional, Bitan, Menachem, additional, Blinderman, Craig D., additional, Bollard, Catherine M., additional, Braun, Benjamin S., additional, Brenner, Malcolm K., additional, Brittenham, Gary M., additional, Brodsky, Robert A., additional, Brown, Myles, additional, Broxmeyer, Hal E., additional, Brummel-Ziedins, Kathleen, additional, Brunner, Andrew M., additional, Buadi, Francis K., additional, Burkhardt, Birgit, additional, Burns, Melissa, additional, Byrd, John C., additional, Caimi, Paolo F., additional, Caligiuri, Michael A., additional, Canavan, Michelle, additional, Cantor, Alan B., additional, Carcao, Manuel, additional, Carroll, Michael C., additional, Carty, Shannon A., additional, Castillo, Jorge J., additional, Chan, Anthony K.C., additional, Chapin, John, additional, Chiu, April, additional, Chute, John P., additional, Clark, David B., additional, Coates, Thomas D., additional, Cogle, Christopher R., additional, Connell, Nathan T., additional, Cooke, Elizabeth, additional, Cooley, Sarah, additional, Corradini, Paolo, additional, Creager, Mark A., additional, Creger, Richard J., additional, Cromwell, Caroline, additional, Crowther, Mark A., additional, Cushing, Melissa M., additional, Cutler, Corey, additional, Dang, Chi V., additional, Danial, Nika N., additional, Dave, Sandeep S., additional, DeCaprio, James A., additional, Dinauer, Mary C., additional, Dinner, Shira, additional, Diz-Küçükkaya, Reyhan, additional, Dodd, Roger Y., additional, Donato, Michele L., additional, Dorshkind, Kenneth, additional, Dotti, Gianpietro, additional, Dror, Yigal, additional, Dunleavy, Kieron, additional, Dvorak, Christopher C., additional, Ebert, Benjamin L., additional, Eck, Michael J., additional, Eikelboom, John W., additional, Epperla, Narendranath, additional, Ershler, William B., additional, Evans, William E., additional, Faderl, Stefan, additional, Ferrara, James L.M., additional, Filipovich, Alexandra Hult, additional, Fischer, Martin, additional, Fredenburgh, James C., additional, Friedman, Kenneth D., additional, Fuchs, Ephraim, additional, Fuller, Stephen J., additional, Gailani, David, additional, Galipeau, Jacques, additional, Gallagher, Patrick G., additional, Ganapathi, Karthik A., additional, Gardner, Lawrence B., additional, Gee, Adrian P., additional, Gerson, Stanton L., additional, Gertz, Morie A., additional, Giardina, Patricia J., additional, Gibson, Christopher J., additional, Golan, Karin, additional, Golub, Todd R., additional, Gonzales, Matthew J., additional, Gotlib, Jason, additional, Gottschalk, Stephen, additional, Grant, Marianne A., additional, Graubert, Timothy A., additional, Gregg, Xylina T., additional, Gribben, John G., additional, Gross, Dawn M., additional, Gruber, Tanja A., additional, Guitart, Joan, additional, Gurbuxani, Sandeep, additional, Gur-Cohen, Shiri, additional, Gutierrez, Alejandro, additional, Hamadani, Mehdi, additional, Hari, Parameswaran N., additional, Hartwig, John H., additional, Hayman, Suzanne R., additional, Hayward, Catherine P.M., additional, Hebbel, Robert P., additional, Heslop, Helen E., additional, Hillis, Christopher, additional, Hillyer, Christopher D., additional, Ho, Karin, additional, Hockenbery, David M., additional, Hoffman, Ronald, additional, Hogg, Kerstin E., additional, Holtan, Shernan G., additional, Horny, Hans-Peter, additional, Hsu, Yen-Michael S., additional, Hunter, Zachary R., additional, Huntington, James A., additional, Iancu-Rubin, Camelia, additional, Iqbal, Ali, additional, Isenman, David E., additional, Israels, Sara J., additional, Italiano, Joseph E., additional, Jaffe, Elaine S., additional, Jaffer, Iqbal H., additional, Jagannath, Sundar, additional, Jäger, Ulrich, additional, Jain, Nitin, additional, James, Paula, additional, Jeha, Sima, additional, Jordan, Michael B., additional, Josephson, Cassandra D., additional, Jung, Moonjung, additional, Kager, Leo, additional, Kambayashi, Taku, additional, Kanakry, Jennifer A., additional, Kantarjian, Hagop M., additional, Kaplan, Jason, additional, Karafin, Matthew S., additional, Karsan, Aly, additional, Kaufman, Randal J., additional, Kaufman, Richard M., additional, Keller, Frank G., additional, Kelly, Kara M., additional, Kessler, Craig M., additional, Key, Nigel S., additional, Keyzner, Alla, additional, Khandoga, Alexander G., additional, Khanna-Gupta, Arati, additional, Khatib-Massalha, Eman, additional, Klein, Harvey G., additional, Knoechel, Birgit, additional, Kollet, Orit, additional, Konkle, Barbara A., additional, Kontoyiannis, Dimitrios P., additional, Koreth, John, additional, Koretzky, Gary A., additional, Kotecha, Dipak, additional, Kremyanskaya, Marina, additional, Kumari, Anju, additional, Kuzel, Timothy M., additional, Küppers, Ralf, additional, Lacy, Martha Q., additional, Ladas, Elana, additional, Landier, Wendy, additional, Lapid, Kfir, additional, Lapidot, Tsvee, additional, Larson, Peter J., additional, Levi, Marcel, additional, Lewis, Russell E., additional, Liebman, Howard A., additional, Lillicrap, David, additional, Lim, Wendy, additional, Lin, Judith C., additional, Lindblad, Robert, additional, Lip, Gregory Y.H., additional, Little, Jane A., additional, Lohr, Jens G., additional, López, José A., additional, Luscinskas, Francis W., additional, Maciejewski, Jaroslaw P., additional, Majhail, Navneet S., additional, Manches, Olivier, additional, Mandle, Robert J., additional, Mann, Kenneth G., additional, Manno, Catherine S., additional, Marcogliese, Andrea N., additional, Mariani, Guglielmo, additional, Marincola, Francesco M., additional, Mascarenhas, John, additional, Massberg, Steffen, additional, McEver, Rodger P., additional, McGrath, Emer, additional, McKinney, Matthew S., additional, Mehta, Rohtesh S., additional, Mentzer, William C., additional, Merlini, Giampaolo, additional, Merryman, Reid, additional, Michel, Marc, additional, Migliaccio, Anna Rita, additional, Miller, Jeffrey S., additional, Mims, Martha P., additional, Mondoro, Traci Heath, additional, Moorehead, Paul, additional, Muniz, Luciana R., additional, Munshi, Nikhil C., additional, Najfeld, Vesna, additional, Nayak, Lalitha, additional, Nazy, Ishac, additional, Neff, Anne T., additional, Ness, Paul M., additional, Notarangelo, Luigi D., additional, O'Brien, Sarah H., additional, O'Connor, Owen A., additional, O'Donnell, Martin, additional, Olson, Amanda, additional, Orkin, Stuart H., additional, Pai, Menaka, additional, Pai, Sung-Yun, additional, Paidas, Michael, additional, Panch, Sandhya R., additional, Pande, Reena L., additional, Papayannopoulou, Thalia, additional, Parikh, Rahul, additional, Petersdorf, Effie W., additional, Peterson, Shane E., additional, Pittaluga, Stefania, additional, Ponce, Doris M., additional, Popolo, Laura, additional, Prchal, Josef T., additional, Pui, Ching-Hon, additional, Puigserver, Pere, additional, Rak, Janusz, additional, Ramos, Carlos A., additional, Rand, Jacob H., additional, Rand, Margaret L., additional, Rao, Dinesh S., additional, Ravandi, Farhad, additional, Rawlings, David J., additional, Reddy, Pavan, additional, Reding, Mark T., additional, Reiter, Andreas, additional, Rice, Lawrence, additional, Riese, Matthew J., additional, Ritchey, Arthur Kim, additional, Roberts, David J., additional, Roman, Elizabeth, additional, Rooney, Cliona M., additional, Rosen, Steven T., additional, Rosenthal, David S., additional, Rossmann, Marlies P., additional, Rot, Antal, additional, Rowley, Scott D., additional, Rubnitz, Jeffrey E., additional, Rydz, Natalia, additional, Salama, Mohamed E., additional, Sauk, Steven, additional, Saunthararajah, Yogen, additional, Savage, William, additional, Scadden, David, additional, Schaefer, Kristen G., additional, Schiffman, Fred, additional, Schneidewend, Robert, additional, Schrier, Stanley L., additional, Schuchman, Edward H., additional, Scullion, Bridget Fowler, additional, Selvaggi, Kathy J., additional, Senoo, Keitaro, additional, Shaheen, Montaser, additional, Shaz, Beth H., additional, Shelburne, Samuel A., additional, Shpall, Elizabeth J., additional, Shurin, Susan B., additional, Siegal, Deborah, additional, Silberstein, Leslie E., additional, Silberstein, Lev, additional, Silverstein, Roy L., additional, Sloan, Steven R., additional, Smith, Franklin O., additional, Smith, James W., additional, Smith, Katy, additional, Steensma, David P., additional, Steinberg, Martin H., additional, Stock, Wendy, additional, Storry, Jill R., additional, Stramer, Susan L., additional, Strauss, Ronald G., additional, Stroncek, David F., additional, Taylor, Justin, additional, Thota, Swapna, additional, Treon, Steven P., additional, Tulpule, Anil, additional, Valdes, Roberto Ferro, additional, Valent, Peter, additional, Vedantham, Suresh, additional, Vercellotti, Gregory M., additional, Verneris, Michael R., additional, Vichinsky, Elliott P., additional, von Andrian, Ulrich H., additional, Vose, Julie M., additional, Wagner, Andrew J., additional, Wang, Ena, additional, Wang, Jia-huai, additional, Warkentin, Theodore E., additional, Wasserstein, Melissa P., additional, Webster, Ann, additional, Weisdorf, Daniel J., additional, Weitz, Jeffrey I., additional, Westhoff, Connie M., additional, Wheeler, Allison P., additional, Widick, Page, additional, Wiley, James S., additional, William, Basem M., additional, Williams, David A., additional, Wilson, Wyndham H., additional, Wolfe, Joanne, additional, Wolgast, Lucia R., additional, Wood, Deborah, additional, Wu, Jennifer, additional, Yahalom, Joachim, additional, Yee, Donald L., additional, Younes, Anas, additional, Young, Neal S., additional, and Zeller, Michelle P., additional

Published
2018
Full Text
View/download PDF

92. Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis

Author

Wurster, Sebastian, primary, Pantaleón García, Jezreel, additional, Albert, Nathaniel D, additional, Jiang, Ying, additional, Bhoda, Keerthi, additional, Kulkarni, Vikram V, additional, Wang, Yongxing, additional, Walsh, Thomas J, additional, Evans, Scott, additional, and Kontoyiannis, Dimitrios P, additional

Published
2023
Full Text
View/download PDF

97. Osteoarticular Mycoses

Author

Gamaletsou, Maria N., primary, Rammaert, Blandine, additional, Brause, Barry, additional, Bueno, Marimelle A., additional, Dadwal, Sanjeet S., additional, Henry, Michael W., additional, Katragkou, Aspasia, additional, Kontoyiannis, Dimitrios P., additional, McCarthy, Matthew W., additional, Miller, Andy O., additional, Moriyama, Brad, additional, Pana, Zoi Dorothea, additional, Petraitiene, Ruta, additional, Petraitis, Vidmantas, additional, Roilides, Emmanuel, additional, Sarkis, Jean-Pierre, additional, Simitsopoulou, Maria, additional, Sipsas, Nikolaos V., additional, Taj-Aldeen, Saad J., additional, Zeller, Valérie, additional, Lortholary, Olivier, additional, and Walsh, Thomas J., additional

Published
2022
Full Text
View/download PDF

98. Reply to Bauer and Goff

Author

Mylonakis, Eleftherios, Clancy, Cornelius J., Ostrosky-Zeichner, Luis, Garey, Kevin W., Alangaden, George J., Vazquez, Jose A., Groeger, Jeffrey S., Judson, Marc A., Vinagre, Yuka-Marie, Heard, Stephen O., Zervou, Fainareti N., Zacharioudakis, Ioannis M., Kontoyiannis, Dimitrios P., and Pappas, Peter G.

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results